Asthma severity: Histopathologic correlations

被引:4
作者
Fish, JE [1 ]
Peters, SB [1 ]
机构
[1] Thomas Jefferson Univ, Jefferson Med Coll, Div Crit Care Pulm Allerg & Immunol Dis, Philadelphia, PA 19107 USA
来源
DRUGS OF TODAY | 1999年 / 35卷 / 08期
关键词
D O I
10.1358/dot.1999.35.8.552215
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Asthma is a disorder characterized by inflammation of the airways which leads to variable airflow obstruction and symptoms of wheezing, chest tightness, cough, and dyspnea. Decisions concerning the type and intensity of therapy for asthma are generally based on the severity of the disease in a given individual. Guidelines for asthma management classify disease severity on the basis of symptom frequency and intensity as well as the degree of physiological impairment. Because treatment decisions are currently not based on markers of airway inflammation, it is important to know how well the underlying inflammatory pathology correlates with clinical and physiological variables and whether airway inflammation, if undertreated, leads to longer term adverse outcomes such as chronic persistent airway obstruction. Studies of asthma pathology reveal an inflammatory response characterized by infiltration of the airways with eosinophils, mast cells and lymphocytes; disruption of the epithelium; thickening of the reticular basement membrane; and increases in smooth muscle mass. These findings are qualitatively found in mild as well as severe asthmatics, and attempts to draw quantitative correlations between severity and intensity of inflammation have yielded discordant results. Although antiinflammatory therapy with corticosteroids decreases the intensity of the inflammation in association with improved clinical variables, the association is circumstantial and it is unclear which marker of inflammation correlates best with the severity of acute episodes or the severity of the disease in patients who are !;table. Problems in relating the underlying pathology to disease severity are largely due to inadequate tissue sampling as bronchoscopically obtained specimens do not permit an evaluation of the outer airway wall or small airways and their surrounding parenchyma. (C) 1999 Prous Science. All rights reserved.
引用
收藏
页码:585 / 594
页数:10
相关论文
共 65 条
[1]   IDENTIFICATION OF ACTIVATED LYMPHOCYTES-T AND EOSINOPHILS IN BRONCHIAL BIOPSIES IN STABLE ATOPIC ASTHMA [J].
AZZAWI, M ;
BRADLEY, B ;
JEFFERY, PK ;
FREW, AJ ;
WARDLAW, AJ ;
KNOWLES, G ;
ASSOUFI, B ;
COLLINS, JV ;
DURHAM, S ;
KAY, AB .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 142 (06) :1407-1413
[2]   IDENTIFICATION OF LYMPHOCYTES-T, MACROPHAGES, AND ACTIVATED EOSINOPHILS IN THE BRONCHIAL-MUCOSA IN INTRINSIC ASTHMA - RELATIONSHIP TO SYMPTOMS AND BRONCHIAL RESPONSIVENESS [J].
BENTLEY, AM ;
MENZ, G ;
STORZ, C ;
ROBINSON, DS ;
BRADLEY, B ;
JEFFERY, PK ;
DURHAM, SR ;
KAY, AB .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (02) :500-506
[3]   Prednisolone treatment in asthma - Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa [J].
Bentley, AM ;
Hamid, Q ;
Robinson, DS ;
Schotman, E ;
Meng, Q ;
Assoufi, B ;
Kay, AB ;
Durham, SR .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (02) :551-556
[4]   EFFECT OF HIGH-DOSE INHALED FLUTICASONE PROPIONATE ON AIRWAY INFLAMMATION IN ASTHMA [J].
BOOTH, H ;
RICHMOND, I ;
WARD, C ;
GARDINER, PV ;
HARKAWAT, R ;
WALTERS, EH .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (01) :45-52
[5]   Bronchial subepithelial fibrosis correlates with airway responsiveness to methacholine [J].
Boulet, LP ;
Laviolette, M ;
Turcotte, H ;
Cartier, A ;
Dugas, M ;
Malo, JL ;
Boutet, M .
CHEST, 1997, 112 (01) :45-52
[6]   EOSINOPHILIC INFLAMMATION IN ASTHMA [J].
BOUSQUET, J ;
CHANEZ, P ;
LACOSTE, JY ;
BARNEON, G ;
GHAVANIAN, N ;
ENANDER, I ;
VENGE, P ;
AHLSTEDT, S ;
SIMONYLAFONTAINE, J ;
GODARD, P ;
MICHEL, FB .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (15) :1033-1039
[7]   INTERLEUKIN-4, INTERLEUKIN-5, AND INTERLEUKIN-6 AND TUMOR-NECROSIS-FACTOR-ALPHA IN NORMAL AND ASTHMATIC AIRWAYS - EVIDENCE FOR THE HUMAN MAST-CELL AS A SOURCE OF THESE CYTOKINES [J].
BRADDING, P ;
ROBERTS, JA ;
BRITTEN, KM ;
MONTEFORT, S ;
DJUKANOVIC, R ;
MUELLER, R ;
HEUSSER, CH ;
HOWARTH, PH ;
HOLGATE, ST .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1994, 10 (05) :471-480
[8]   EOSINOPHILS, T-LYMPHOCYTES, MAST-CELLS, NEUTROPHILS, AND MACROPHAGES IN BRONCHIAL BIOPSY SPECIMENS FROM ATOPIC SUBJECTS WITH ASTHMA - COMPARISON WITH BIOPSY SPECIMENS FROM ATOPIC SUBJECTS WITHOUT ASTHMA AND NORMAL CONTROL SUBJECTS AND RELATIONSHIP TO BRONCHIAL HYPERRESPONSIVENESS [J].
BRADLEY, BL ;
AZZAWI, M ;
JACOBSON, M ;
ASSOUFI, B ;
COLLINS, JV ;
IRANI, AMA ;
SCHWARTZ, LB ;
DURHAM, SR ;
JEFFERY, PK ;
KAY, AB .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1991, 88 (04) :661-674
[9]   MYOFIBROBLASTS AND SUBEPITHELIAL FIBROSIS IN BRONCHIAL-ASTHMA [J].
BREWSTER, CEP ;
HOWARTH, PH ;
DJUKANOVIC, R ;
WILSON, J ;
HOLGATE, ST ;
ROCHE, WR .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1990, 3 (05) :507-511
[10]   Relative effects of inhaled corticosteroids on immunopathology and physiology in asthma: A controlled study [J].
Burke, CM ;
Sreenan, S ;
Pathmakanthan, S ;
Patterson, J ;
Schmekel, B ;
Poulter, LW .
THORAX, 1996, 51 (10) :993-999